Schedule 13G ownership disclosure
Taxus Cardium Pharmaceuticals Group Inc.
Security class unavailable · CUSIP: 876767104
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-22-000040
- Form type
- SC 13G
- Filer
- Gene Biotherapeutics, Inc.
- CIK
- CIK 772320
- Filed
- Jan 05, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership